We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 13, 2021

The VHL Point Mutation R167Q in Hereditary VHL Disease Interferes With Cell Plasticity Regulation

Cancers

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancers
The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes With Cell Plasticity Regulation
Cancers (Basel) 2021 Aug 02;[EPub Ahead of Print], S Buart, S Terry, MK Diop, P Dessen, S Couvé, A Abdou, J Adam, J Thiery, P Savagner, S Chouaib

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading